U.S. Representative Morgan Griffith (R), with lead Democratic co-sponsor, Rep. Angie Craig re-introduced two bills in the U.S. House that would require the Food and Drug Administration to regulate hemp-derived cannabidiol (CBD).

There is no doubt that CBD regulations would be a burning topic among many other issues at the Benzinga Cannabis Capital Conference in Miami (April 11-12) where top CEOs, investors, leaders, advocates and politicians will share their thoughts, ideas and experiences.

The Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act of 2023, would subject hemp extract products to the regulatory framework for dietary supplements; while the CBD Product Safety and Standardization Act of 2023, would establish regulations for CBD as a food and …

Full story available on Benzinga.com